A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy

Human Molecular Genetics

Volumn 17, Issue 14, 2008, Pages 2118-2131

  Matera, Ivana ^a,b   Watkins Chow, Dawn E ^a   Loftus, Stacie K ^a   Hou, Ling ^a   Incao, Arturo ^a   Silver, Debra L ^a   Rivas, Cecelia ^a   Elliott, Eugene C ^a   Baxter, Laura L ^a   Pavan, William J ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR MOS1; TRANSCRIPTION FACTOR MOS2; TRANSCRIPTION FACTOR MOS3; TRANSCRIPTION FACTOR SOX10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CELL SPECIFICITY; CHROMOSOME 13; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; EMBRYO; FEASIBILITY STUDY; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY; LINKAGE ANALYSIS; MALE; MELANOCYTE; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; NEURAL CREST; NEUROCRISTOPATHY; NONHUMAN; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WAARDENBURG SYNDROME;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CHROMOSOME MAPPING; CODON, NONSENSE; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; ETHYLNITROSOUREA; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC COMPLEMENTATION TEST; HIGH MOBILITY GROUP PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MELANOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTAGENESIS; MUTAGENS; NERVE TISSUE PROTEINS; NEURAL CREST; PIGMENTATION; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; WAARDENBURG'S SYNDROME;

ERINACEIDAE; MUS;

EID: 46249117044     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn110     Document Type: Article

References (66)

1. Baldwin, C.T., Roth, C.F., Amos, J.A., da-Silva, E.O. and Milunsky, A. (1992) An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature, 355, 637-638.
2. Bondurand, N., Dastot-Le Moal, F., Stanchina, L., Collot, N., Barai, V., Marlin, S., Attie-Bitach, T., Giurgea, I., Skopinski, L., Reardon, W. et al. (2007) Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am. J. Hum. Genet., 81, 1169-1185.
3. Tassabehji, M., Read, A.P., Newton, V.E., Harris, R., Balling, R., Gruss, P. and Strachan, T. (1992) Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635-636.
4. Tassabehji, M., Newton, V.E. and Read, A.P. 0994) Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet., 8, 251-255.
5. Sanchez-Martin, M., Rodriguez-Garcia, A., Perez-Losada, J., Sagrera, A., Read, A.P. and Sanchez-Garcia, I. (2002) SLUG (SNA12) deletions in patients with Waardenburg disease. Hum. Mol. Genet., 11, 3231-3236.
6. Puffenberger, E.G., Hosoda, K., Washington, S.S., Nakao, K., deWit, D., Yanagisawa, M. and Chakravart, A. (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 74, 1257-1266.
7. Hofstra, R.M., Osinga, J., Tan-Sindhunata, G., Wu, Y., Kamsteeg, E.J., Stulp, R.P., van Ravenswaaij-Arts, C., Majoor-Krakauer, D., Angrist, M., Chakravarti, A. et al. (1996) A homozygous mutation in the EDN3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat. Genet., 12, 445-447.
8. Edery, P., Attie, T., Amiel, J., Pelet, A., Eng, C., Hofstra, R.M., Martelli, H., Bidaud, C., Munnich, A. and Lyonnet, S. (1996) Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat. Genet., 12, 442-444.
9. Pingault, V., Bondurand, N., Kuhlbrodt, K., Gocrich, D.E., Prehu, M.O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G. et al. (1998) SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet., 18, 171-173.
10. Mollaaghababa, R. and Pavan, W.J. (2003) The importance of having your SOX on: Role of SOX10 in the development of neural crest-derived. melanocytes and glia. Oncogene, 22, 3024-3034.
11. Silver, D.L., Hou, L. and Pavan, W.J. (2006) The genetic regulation of pigment cell development. Adv. Exp. Med. Biol., 589, 155-169.
12. Southard-Smith, E.M., Kos, L. and Pavan, W.J. (1998) Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet., 18, 60-64.
13. Britsch, S., Goerich, D.E., Riethmacher, D., Peirano, R.I., Rossner, M., Nave, K.A., Birchmeier, C. and Wegner, M. (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev., 15, 66-78.
14. Tachibana, M., Kobayashi, Y. and Matsushima, Y. (2003) Mouse models for four types of Waardenburg syndrome. Pigment Cell Res., 16, 448-454.
15. Johnson, D.R. (1967) Extra-toes: Anew mutant gene causing multiple abnormalities in the mouse. J. Embryol. Exp. Morphol., 17, 543-581.
16. Dickie, M.M. (1967) Presumed recurrences of mutations. Mouse News Lett., 36, 60.
17. Kang, S., Graham, J.M., Jr, Olney, A.H. and Biesecker, L.G. (1997) GL13 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet., 15, 266-268.
18. Vortkamp, A., Gessler, M. and Grzeschik, K,H. (1991) GL13 zinc-finger gene interrupted by translocations in Greig syndrome families. Nature 352, 539-540.
19. Johnston, J.J., Olivos-Glander, I., Killoran, C., Elson, E., Turner, J.T., Peters, K.F., Abbott, M.H., Aughton, D.J., Aylsworth, A.S., Bamshad, M.J. et al. (2005) Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: Robust phenotype prediction from the type and position of GL13 mutations. Am. J. Hum. Genet., 76, 609-622.
20. Hui, C.C. and Joyner, A.L. (1993) A mouse model of Greig cephalopolysyndactyly syndrome: The extra-toesJ mutation contains an intragenic deletion of the Gli3 gene. Nat. Genet., 3, 241-246.
21. Pavan, W.J. and Tilghman, S.M. (1994) Piebald lethal (s1) acts early to disrupt the development of neural crest-derived melanocytes. Proc. Natl Acad. Sci. USA, 91, 7159-7163.
22. Mackenzie, M.A., Jordan, S.A., Budd, P.S. and Jackson, I.J. (1997) Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol., 192, 99-107.
23. Hakami, R.M., Hou, L., Baxter, L.L., Loftus, S.K., Southard-Smith, E.M., Incao, A., Cheng, J. and Pavan, W.J. (2006) Genetic evidence does not support direct regulation of EDNRB by SOX10 in migratory neural crest and the melanocyte lineage. Mech. Dev., 123, 124-134.
24. Rash, B.G. and Grove, E.A. (2007) Patterning the dorsal telencephalon: A role for sonic hedgehog? J. Neurosci., 27, 11595-11603.
25. Jiao, Z., Zhang, Z.G., Homyak, T.J., Hozeska, A., Zhang, R.L., Wang, Y., Wang, L., Roberts, C., Strickland, F.M. and Chopp, M. (2006) Dopachrome tautomerase (Dct) regulates neural progenitor cell proliferation. Dev. Biol., 296, 396-408.
26. Wang, B., Fallon, J.F. and Beachy, P.A. (2000) Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell, 100, 423-434.
27. Bose, J., Grotewold, L. and Ruther, U. (2002) Pallister-Hall syndrome phenotype in mice mutant for Gli3. Hum. Mol. Genet., 11, 1129-1135.
28. Flint, J., Valdar, W., Shifman, S. and Mott, R. (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nat. Rev. Genet., 6, 271-286.
29. Yang, H., Bell, T.A., Churchill, G.A. and Pardo-Manuel de Villena, F. (2007) On the subspecific origin of the laboratory mouse. Nat. Genet. 39, 1100-1107.
30. St Johnston, D. (2002) The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet., 3, 176-188.
31. Carpinelli, M. R., Hilton, D.J., Metcalf, D., Antonchuk, J.L., Hyland, C.D., Mifsud, S.L., Di Rago, L., Hilton, A.A., Willson, T.A., Roberts, A.W. et al. (2004) Suppressor screen in Mpl -/- mice: C-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl Acad. Sci. USA, 101, 6553-6558.
32. Speca, D.J., Rabbee, N., Chihara, D., Speed, T.P. and Peterson, A.S. (2006) A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice. Genes Brain. Behav., 5, 19-28.
33. Nadeau, J.H. and Frankel, W.N. (2000) The roads from phenotypic variation to gene discovery: Mutagenesis versus QTLs. Nat. Genet., 25, 381-384.
34. Ruppert, J.M., Vogelstein, B., Arheden, K. and Kinzler, K.W. (1990) GL13 encodes a 190-kilodalton protein with multiple regions of GLI similarity. Mol. Cell. Biol., 10, 5408-5415.
35. Ruiz i Altaba, A. (1999) Gli proteins and Hedgehog signaling: development and cancer. Trends Genet., 15, 418-425.
36. Lee, J., Platt, K.A., Censullo, P. and Ruiz i Altaba, A. (1997) Gli1 is a target of sonic hedgehog that induces ventral neural tube development. Development, 124, 2537-2552.
37. Silver, D., Hou, L., Somerville, R., Young, M., Apte, S. and Pavan, W. (2008) The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS Genet, 4, e1000003 doi:10.1371/ journal.pgen.1000003.
38. Ruiz i Altaba, A., Nguyen, V. and Palma, V. (2003) The emergent design of the neural tube: Prepattern, SHH morphogen and GLI code. Curr. Opin. Genet. Dev., 13, 513-521.
39. Biesecker, L.G. (2006) What you can learn from one gene: GL13. J. Med. Genet., 43, 465-469.
40. Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H. and Pavan, W.J. (2000) Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet., 107, 1-6.
41. Lee, M., Goodall, J., Verastegui, C., Ballotti, R. and Goding, C.R. (2000) Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem., 275, 37978-37983.
42. Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M. and Goossens, M. (2000) Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet., 9, 1907-1917.
43. Verastegui, C., Bille, K., Ortonne, J.P. and Ballotti, R. (2000) Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J. Biol. Chem., 275, 30757-30760.
44. Werner, T., Hammer, A., Wahlbuhl, M., Bosl, M.R. and Wegner, M. (2007) Multiple conserved regulatory elements with overlapping functions determine Sox10 expression in mouse embryogenesis. Nucleic Acids Res. 35, 6526-6538.
45. Aoki, Y., Saint-Germain, N., Gyda, M., Magner-Fink, E., Lee, Y.H., Credidio, C. and Saint-Jeannet, J.P. (2003) Sox10 regulates the development of neural crest-derived melanocytes in Xenopus. Dev. Biol., 259, 19-33.
46. Alvarez-Medina, R., Cayuso, J., Okubo, T., Takada, S. and Marti, E. (2008) Wnt canonical pathway restficts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development, 135, 237-247.
47. Ulloa, F., Itasaki, N. and Briscoe, J. (2007) Inhibitory Gli3 activity negatively regulates Wnt/beta-catenin signaling. Curr., Biol., 17, 545-550.
48. Dunn, K.J., Brady, M., Ochsenbauer-Jambor, C., Snyder, S., Incao, A. and Pavan, W.J. (2005) WNT1 and WNT3a promote expansion of melanocytes through distinct modes of action. Pigment Cell Res., 18, 167-180.
49. Hari, L., Brault, V., Kleber, M., Lee, H.Y., Ille, F., Leimeroth, R., Paratore, C., Suter, U., Kemler, R. and Sommer, L. (2002) Lineage-specific requirements of beta-catenin in neural crest development. J. Cell. Biol., 159, 867-880.
50. Jin, E.J., Erickson, C.A., Takada, S. and Burrus, L.W. (2001) Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. Dev. Biol., 233, 22-37.
51. Takeda, K., Yasumoto, K., Takada, R., Takada, S., Watanabe, K., Udono. T., Saito, H., Takahashi, K. and Shibahara, S. (2000) Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J. Biol. Chem., 275, 14013-14016.
52. Dorsky, R.I., Moon, R.T. and Raible, D.W. (1998) Control of neural crest cell fate by the Wnt signalling pathway. Nature, 396, 370-373.
53. Dorsky, R.I., Raible, D.W. and Moon, R.T. (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev., 14, 158-162.
54. Saito, H., Yasumoto, K., Takeda, K., Takahashi, K., Yamamoto, H. and Shibahara, S. (2003) Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Res., 16, 261-265.
55. Dorsky, R.I., Moon, R.T. and Raible, D.W. (2000) Environmental signals and cell fate specification in premigratory neural crest. Bioessays 22, 708-716.
56. Jeong, J., Mao, J., Tenzen, T., Kottmann, A.H. and McMahon, A.P. (2004) Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev., 18, 937-951.
57. Ignatius, M.S., Moose, H.E., El-Hodiri, H.M. and Henion, P.D. (2007) Colgate/hdacl repression of foxd3 expression is required to permit mitfa-dependent melanogenesis. Dev. Biol., 313, 569-583.
58. Justice, M. (2000) Mutagenesis of the mouse germline. In Jackson, I.J. and Abbott, C.M. (eds), Mouse Genetics and Transgenics: A Practical Approach. Oxford University Press, Oxford, UK, pp. 185-214.
59. Silver, L. (1995) Classical linkage analysis and mapping panels. In Mouse Genetics: Concepts and Applications. Oxford University Press, UK.
60. Wilkinson, D.G. and Nieto, M.A. (1993). In Wassarman, P. and DePamphilis, M. (eds), Methods in Enzymology: Guide to Techniques in Mouse Development. Academic, San Diego, pp. 361-373.
61. Selicorni, A., Guerneri, S., Ratti, A. and Pizzuti, A. (2002) Cytogenetic mapping of a novel locus for type II Waardenburg syndrome. Hum. Genet., 110, 64-67.
62. Southard-Smith, E.M., Angrist, M., Ellison, J.S., Agarwala, R., Baxevanis, A.D., Chakravarti, A. and Pavan, W.J. (1999) The Sox10(Dom) mouse: Modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res., 9, 215-225.
63. Rhim, H., Dunn, K.J., Aronzon, A., Mac, S., Cheng, M., Lamoreux, M.L., Tilghman, S.M. and Pavan, W.J. (2000) Spatially restricted hypopigmentation associated with an Ednrbs-modifying locus on mouse chromosome 10. Genome Res., 10, 17-29.
64. Dai, P., Akimaru, H., Tanaka, Y., Maekawa, T., Nakafuku, M. and Ishii, S. (1999) Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GL13. J. Biol. Chem., 274, 8143-8152.
65. Kalff-Suske, M., Wild, A., Topp, J., Wessling, M., Jacobsen, E.M., Bornholdt, D., Engel, H., Heuer, H., Aalfs, C.M., Ausems, M.G. et al (1999) Point mutations throughout the GL13 gene cause Greig cephalopolysyndactyly syndrome. Hum. Mol. Genet., 8, 1769-1777.
66. Zhou H., Kim, S., Ishii, S. and Boyer, T.G. (2006) Mediator modulates Gli3-dependent Sonic hedgehog signaling. Mol. Cell. Biol., 26 8667-8682.